Transcriptome instability in colorectal cancer identified by exon microarray analyses: Associations with splicing factor expression levels and patient survival.
about
MicroRNAs as growth regulators, their function and biomarker status in colorectal cancerTIN: An R Package for Transcriptome Instability AnalysisUp-regulation of the mitotic checkpoint component Mad1 causes chromosomal instability and resistance to microtubule poisonsThe recently suggested intestinal cancer stem cell marker DCLK1 is an epigenetic biomarker for colorectal cancer.Phospholipase C isozymes are deregulated in colorectal cancer--insights gained from gene set enrichment analysis of the transcriptome.Truncated neurokinin-1 receptor is increased in colonic epithelial cells from patients with colitis-associated cancer.Transcriptome instability as a molecular pan-cancer characteristic of carcinomasMiR-9, -31, and -182 deregulation promote proliferation and tumor cell survival in colon cancer.Novel RNA variants in colorectal cancers.The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancersSplicing programs and cancerC9ORF72 GGGGCC Expanded Repeats Produce Splicing Dysregulation which Correlates with Disease Severity in Amyotrophic Lateral SclerosisOncogenicity of the developmental transcription factor Sox9.MYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastoma.ColoFinder: a prognostic 9-gene signature improves prognosis for 871 stage II and III colorectal cancer patients.Pathway-based personalized analysis of cancerCommon fusion transcripts identified in colorectal cancer cell lines by high-throughput RNA sequencing.Important molecular genetic markers of colorectal cancer.Loss of Myosin Vb in colorectal cancer is a strong prognostic factor for disease recurrence.Autocrine WNT2 signaling in fibroblasts promotes colorectal cancer progression.NIT1 suppresses tumour proliferation by activating the TGFβ1-Smad2/3 signalling pathway in colorectal cancer.Inflammatory genes are novel prognostic biomarkers for colorectal cancer.Integrative analysis reveals functional and regulatory roles of H3K79me2 in mediating alternative splicing.The exon-level biomarker SLC39A14 has organ-confined cancer-specificity in colorectal cancer.Profiles of alternative splicing in colorectal cancer and their clinical significance: A study based on large-scale sequencing data
P2860
Q26775610-18DE23F7-A290-47E7-8228-9C3F73DD4EDEQ26786118-44174F5D-AF64-4487-BB02-768AE34265ACQ30524222-D30833B3-B844-4AC6-AA2F-6C704448C0CFQ33740655-E203B227-3624-467D-B409-FF6E1E303DBDQ34016649-616276AA-60BE-4B7B-BC7F-3F96407425E3Q34039324-F4BE6684-2700-49B1-9EED-14040ACD1397Q34041693-F8480726-C6F6-43BD-9F86-BB19AC9EDAA8Q34423582-CDA33D08-1FB4-4C2B-97BF-330574333766Q34498285-8A7772A8-D12D-4273-8A59-F8884AB94FC0Q34776216-86703CC5-8735-4A86-907D-82F573710C02Q35450183-E82DC1B9-EFE9-4318-B7F1-6853F89015C3Q35643260-BAE3F1A2-0C79-4BBD-BA23-5E8D5E544C72Q36043468-B2E3CBC4-68B5-49D4-B3BA-23E29BB417EAQ36535291-C4863CA3-C48B-4FD8-AB2C-3AB1AEE77E72Q36691267-5994E23D-ADAF-4EEC-814D-58911DC01A59Q36782228-75044422-DD4A-4B57-ACE7-BF376642CBF6Q37236012-B931AC5D-4B10-4B63-9A4A-CBA16888F110Q37619856-FD00F344-2E2E-4A6D-B159-78B543AF4CD1Q47661261-7C0D1534-7990-4732-A15A-8144D99DCF66Q48365002-C47B6372-183B-422E-B683-9E349B69835EQ49958338-63285842-6315-460F-8F59-4292EADBA124Q52564403-2FB5643B-CF2C-43C8-888C-4DBFCC4366AAQ52582426-68EAF7F3-CE57-40F2-AEC4-70630E693D75Q54333814-ACB9154C-A14B-4769-BEE9-20CD3C98E6ECQ58714868-38DBAB58-5676-4919-9B1A-42C3373674F6
P2860
Transcriptome instability in colorectal cancer identified by exon microarray analyses: Associations with splicing factor expression levels and patient survival.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Transcriptome instability in c ...... n levels and patient survival.
@ast
Transcriptome instability in c ...... n levels and patient survival.
@en
Transcriptome instability in c ...... n levels and patient survival.
@nl
type
label
Transcriptome instability in c ...... n levels and patient survival.
@ast
Transcriptome instability in c ...... n levels and patient survival.
@en
Transcriptome instability in c ...... n levels and patient survival.
@nl
prefLabel
Transcriptome instability in c ...... n levels and patient survival.
@ast
Transcriptome instability in c ...... n levels and patient survival.
@en
Transcriptome instability in c ...... n levels and patient survival.
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
Transcriptome instability in c ...... n levels and patient survival.
@en
P2093
Anita Sveen
Torleiv O Rognum
Trude H Agesen
P2860
P2888
P356
10.1186/GM248
P577
2011-05-27T00:00:00Z
P5875
P6179
1024232880